Last update 02 Apr 2024

Zabedosertib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
IRAK-4 inhibitor
+ [1]
Target
Mechanism
IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC20H21F3N4O4S
InChIKeyOQAMEEFUUFJZRS-UHFFFAOYSA-N
CAS Registry1931994-81-8

R&D Status

IndicationHighest PhaseCountry/LocationOrganization
Dermatitis, AtopicPhase 2US
More
Rheumatoid ArthritisPhase 1DE
More
-Phase 1DE
More
PsoriasisPhase 1DE
More
Pelvic Inflammatory DiseasePendingNL
More
Login to view more data

Clinical Trial Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial Analysis

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free